Jim Coccia | Partner
TKG Access

Jim Coccia is Founder and Partner at TKG Access, a leading consultancy specializing in orphan drug and rare disease access strategies. With over 30 years of experience in the pharmaceutical and healthcare industries, Jim has a proven track record of developing innovative solutions to improve patient access to life-changing therapies.

Throughout his career, Jim has worked closely with pharmaceutical companies, patient advocacy groups, healthcare providers, and payers to navigate the complex landscape of orphan drug development and market access. His expertise lies in creating tailored market access strategies that address the unique challenges faced by orphan drug developers, ensuring that patients have timely and affordable access to the treatments they need.

Jim is passionate about making a difference in the lives of patients with rare diseases and is committed to ensuring access to therapies. His strategic insights and collaborative approach have helped numerous companies successfully bring their orphan drugs to market and navigate the evolving reimbursement environment.

As a speaker at the World Orphan Drug Congress USA 2025, Jim brings a wealth of knowledge and expertise to the discussion on orphan drug access. His insights into market access challenges and opportunities in the rare disease space make him a valuable resource for industry professionals looking to make a meaningful impact in this critical area of healthcare.